AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionEverett Harris & Co /ca/
Latest Disclosed Ownership513,391 shares
Latest Disclosed Value $ 111,657,409
Everett Harris & Co /ca/ reports 0.69% decrease in ownership of 4AB / AbbVie Inc.

On May 8, 2026 - Everett Harris & Co /ca/ filed a 13F-HR form disclosing ownership of 513,391 shares of AbbVie Inc. (BG:4AB) valued at $111,657,409 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 516,966 shares of AbbVie Inc.. This represents a change in shares of -0.69% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F AbbVie COM 00287Y109 513,391 -3,575 -0.69 111,657 -5.47 1.4370
2026-02-11 2025-12-31 13F AbbVie COM 00287Y109 516,966 -868 -0.17 118,122 -1.48 1.4290
2025-11-03 2025-09-30 13F AbbVie COM 00287Y109 517,834 -3,425 -0.66 119,899 23.92 1.4784
2025-08-08 2025-06-30 13F AbbVie COM 00287Y109 521,259 -2,890 -0.55 96,756 -11.90 1.2415
2025-05-12 2025-03-31 13F AbbVie COM 00287Y109 524,149 -3,908 -0.74 109,820 17.03 1.4102
2025-01-24 2024-12-31 13F ABBVIE COM 00287Y109 528,057 -813 -0.15 93,836 -10.16 1.1850
2024-10-18 2024-09-30 13F ABBVIE COM 00287Y109 528,870 -2,360 -0.44 104,441 14.62 1.2950
2024-08-02 2024-06-30 13F ABBVIE COM 00287Y109 531,230 -2,454 -0.46 91,117 -6.24 1.1655
2024-04-19 2024-03-31 13F ABBVIE COM 00287Y109 533,684 -3,392 -0.63 97,184 16.76 1.2877
2024-01-18 2023-12-31 13F ABBVIE COM 00287Y109 537,076 -3,933 -0.73 83,231 3.21 1.1907
2023-10-24 2023-09-30 13F ABBVIE COM 00287Y109 541,009 -4,629 -0.85 80,643 9.70 1.2576
2023-07-27 2023-06-30 13F ABBVIE COM 00287Y109 545,638 -6,655 -1.20 73,514 -16.48 1.1158
2023-04-25 2023-03-31 13F ABBVIE COM 00287Y109 552,293 -1,055 -0.19 88,019 -1.58 1.4268
2023-01-20 2022-12-31 13F ABBVIE COM 00287Y109 553,348 -2,010 -0.36 89,427 19.98 1.5375
2022-10-21 2022-09-30 13F ABBVIE COM 00287Y109 555,358 1,160 0.21 74,535 -12.19 1.3717
2022-07-22 2022-06-30 13F ABBVIE COM 00287Y109 554,198 -6,373 -1.14 84,881 -6.59 1.4681
2022-04-22 2022-03-31 13F ABBVIE COM 00287Y109 560,571 1,569 0.28 90,874 20.06 1.2922
2022-02-02 2021-12-31 13F ABBVIE COM 00287Y109 559,002 45,083 8.77 75,689 36.53 1.0501
2021-11-03 2021-09-30 13F ABBVIE COM 00287Y109 513,919 16,551 3.33 55,436 -1.05 0.8763
2021-07-29 2021-06-30 13F ABBVIE COM 00287Y109 497,368 22,903 4.83 56,024 9.11 0.8962
2021-05-13 2021-03-31 13F ABBVIE COM 00287Y109 474,465 69,949 17.29 51,347 18.46 0.8908
2021-02-04 2020-12-31 13F ABBVIE COM 00287Y109 404,516 39,004 10.67 43,344 35.39 0.7664
2020-11-03 2020-09-30 13F ABBVIE COM 00287Y109 365,512 159 0.04 32,015 -10.75 0.6254
2020-07-29 2020-06-30 13F ABBVIE COM 00287Y109 365,353 883 0.24 35,870 29.17 0.7912
2020-04-29 2020-03-31 13F ABBVIE COM 00287Y109 364,470 9,972 2.81 27,769 -11.53 0.7151
2020-01-27 2019-12-31 13F AbbVie COM 00287Y109 354,498 -1,023 -0.29 31,387 16.59 0.7094
2019-11-06 2019-09-30 13F AbbVie COM 00287Y109 355,521 -10,987 -3.00 26,920 1.01 0.6652
2019-08-13 2019-06-30 13F AbbVie COM 00287Y109 366,508 6,003 1.67 26,652 -8.26 0.6670
2019-05-13 2019-03-31 13F AbbVie COM 00287Y109 360,505 -2,010 -0.55 29,053 -13.07 0.7535
2019-02-13 2018-12-31 13F AbbVie COM 00287Y109 362,515 -16,001 -4.23 33,420 -6.65 0.9489
2018-11-14 2018-09-30 13F AbbVie COM 00287Y109 378,516 1,221 0.32 35,800 2.41 0.8971
2018-07-27 2018-06-30 13F AbbVie COM 00287Y109 377,295 128 0.03 34,956 -2.08 0.9520
2018-04-20 2018-03-31 13F AbbVie COM 00287Y109 377,167 2,944 0.79 35,699 -1.36 0.9888
2018-02-01 2017-12-31 13F/A-1 AbbVie COM 00287Y109 374,223 -615 -0.16 36,191 8.66 1.0088
2018-01-30 2017-12-31 13F AbbVie COM 00287Y109 374,838 0 33,308
2017-10-11 2017-09-30 13F AbbVie COM 00287Y109 374,838 -60,857 -13.97 33,308 5.43 0.9997
2017-08-03 2017-06-30 13F AbbVie COM 00287Y109 435,695 -2,696 -0.61 31,592 10.59 0.9777
2017-04-26 2017-03-31 13F AbbVie COM 00287Y109 438,391 -6,520 -1.47 28,566 2.53 0.9349
2017-02-07 2016-12-31 13F AbbVie COM 00287Y109 444,911 -758 -0.17 27,860 -0.88 0.9782
2016-10-26 2016-09-30 13F AbbVie COM 00287Y109 445,669 -3,592 -0.80 28,108 1.06 0.9938
2016-08-03 2016-06-30 13F AbbVie COM 00287Y109 449,261 -6,724 -1.47 27,814 6.79 0.9929
2016-04-26 2016-03-31 13F AbbVie COM 00287Y109 455,985 -10,714 -2.30 26,046 -5.79 0.9361
2016-02-09 2015-12-31 13F AbbVie COM 00287Y109 466,699 -6,825 -1.44 27,647 7.31 0.9651
2015-11-12 2015-09-30 13F AbbVie COM 00287Y109 473,524 -2,774 -0.58 25,764 -19.49 0.9446
2015-08-12 2015-06-30 13F AbbVie COM 00287Y109 476,298 -1,270 -0.27 32,002 14.47 1.1236
2015-05-12 2015-03-31 13F AbbVie COM 00287Y109 477,568 425 0.09 27,957 -10.46 0.9582
2015-02-11 2014-12-31 13F AbbVie COM 00287Y109 477,143 -19,613 -3.95 31,224 8.82 1.0679
2014-11-06 2014-09-30 13F AbbVie COM 00287Y109 496,756 -9,386 -1.85 28,693 0.44 1.0347
2014-08-05 2014-06-30 13F AbbVie COM 00287Y109 506,142 -970 -0.19 28,567 9.59 1.0550
2014-05-19 2014-03-31 13F AbbVie COM 00287Y109 507,112 -8,783 -1.70 26,066 -4.32 0.9695
2014-02-13 2013-12-31 13F AbbVie COM 00287Y109 515,895 -25,902 -4.78 27,244 12.42 1.0183
2013-11-01 2013-09-30 13F AbbVie COM 00287Y109 541,797 -65,499 -10.79 24,235 -3.47 0.9884
2013-07-24 2013-06-30 13F AbbVie COM 00287Y109 607,296 607,296 25,106 1.0468
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.